Thomas C Varvaro insider trades: Mabvax Therapeutics Holdings (MBVX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Thomas reports to the SEC
Open-market buys and sales
5 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jan 24, 2018 | MBVX | ↓ Sell | 35,441 | $0.85 | $30K | Direct | Jan 24, 2018 (0d) |
| Aug 25, 2014 | CDXC.OB | ↑ Buy | 2,250 | $1.09 | $2K | Direct | Aug 25, 2014 (0d) |
| Aug 22, 2014 | CDXC.OB | ↑ Buy | 1,250 | $1.20 | $2K | Direct | Aug 22, 2014 (0d) |
| Dec 9, 2011 | CDXC.OB | ↑ Buy | 2,000 | $0.65 | $1K | Direct | Dec 13, 2011 (4d) |
| Dec 7, 2011 | CDXC.OB | ↑ Buy | 1,500 | $0.63 | $945 | Direct | Dec 8, 2011 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Thomas C Varvaro's insider trades
Thomas C Varvaro is an insider at Mabvax Therapeutics Holdings (MBVX). Since Dec 7, 2011, Thomas has reported 4 open-market purchases worth $6K and 1 sale worth $30K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (19 filings), option exercises (4 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MBVX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.